The acquisition of health data (biomarkers, vital signals, etc.) on the field will revolutionize medicine by improving the management, diagnosis and monitoring of pathologies.
However, there are still very few solutions that allow for continuous data acquisition other than vital signals and blood sugar levels. To broaden the spectrum of applications by offering a wider range of biomarkers, Grapheal is developing a new generation of connected medical devices (in-vitro diagnostic tests, skin patches) to facilitate and accelerate decision-making by caregivers in a digital and decentralized healthcare system.
Grapheal's mission is to create a portfolio of non-invasive smartphone‐based biosensors for real-time and rapid sensing outside laboratories, with easy integration into third-party solutions.
Grapheal deploys its technology on two different use cases:
© Grapheal 2022